Alkermes Plc news

   Watch this stock
Showing stories 1 - 10 of about 93   

Articles published

ALKS 43.51 +0.65 (1.52%)
price chart
Alkermes plc (ALKS) Announces Third ALKS 5461 Phase 3 Met Primary Endpoint in MDD
Alkermes plc (NASDAQ: ALKS) announced positive topline results from FORWARD-5, the third phase 3 efficacy study to read out from the FORWARD pivotal program for ALKS 5461, a once-daily, oral investigational medicine with a novel mechanism of action ...
Alkermes depression drug succeeds in key trial, shares surge  Reuters
Alkermes Surges as Depression Drug Hits Goal in Late Trial  Bloomberg
Alkermes plc (NASDAQ:ALKS) lost about -16 percent in value since last earnings
Alkermes plc (NASDAQ:ALKS) is due to announce third quarter financial results right before the stock market's official open on October 27, 2016.
Q3 2016 EPS Estimates for Alkermes PLC Reduced by Analyst (ALKS)
Alkermes PLC logo Alkermes PLC (NASDAQ:ALKS) - Equities research analysts at Jefferies Group decreased their Q3 2016 earnings per share estimates for Alkermes PLC in a note issued to investors on Wednesday. Jefferies Group analyst B. Amin now ...
Q3 2016 EPS Estimates for Alkermes PLC (ALKS) Reduced by Jefferies Group  BBNS
Alkermes PLC (ALKS) Position Lowered by Tocqueville Asset Management L.P.  DailyQuint
Jefferies Group Analysts Cut Earnings Estimates for Alkermes PLC (ALKS)
Alkermes PLC logo Alkermes PLC (NASDAQ:ALKS) - Equities research analysts at Jefferies Group lowered their Q3 2016 earnings estimates for Alkermes PLC in a report released on Wednesday. Jefferies Group analyst B. Amin now expects that the ...
Next Weeks Broker Price Targets For Alkermes Plc (NASDAQ:ALKS)  Fiscal Standard
Today's Stock Alert: What's Alkermes Plc Upside After Today's Big Increase?
Analysts await Alkermes Plc (NASDAQ:ALKS) to report earnings on November, 3. They expect $-0.20 EPS, up 52.38% or $0.22 from last year's $-0.42 per share.
Alkermes PLC (ALKS) Stock Rating Lowered by Zacks Investment Research  BBNS
Short Interest To Observe: Alkermes Plc Ord (NASDAQ:ALKS)'s Stock Is ...  Post News
Option Market: Alkermes plc Risk Hits An Amplified Level
This is a proprietary risk rating for the next 30-days built by Capital Market Laboratories (CMLviz) based on a large number of interactions of data points, many of which come directly from the option market for Alkermes plc (NASDAQ:ALKS) . We also ...
Alkermes Launches Competitive Grants Program to Support People Affected by ...
DUBLIN--(BUSINESS WIRE)--Alkermes plc (NASDAQ: ALKS), a global biopharmaceutical company developing medicines for the treatment of central nervous system (CNS) diseases, such as schizophrenia, major depressive disorder and multiple sclerosis, ...
Comprehensive Stock Analysis of: Alkermes plc (NASDAQ:ALKS)
Alkermes plc (NASDAQ:ALKS) reported its last earnings on Oct 27 BMO (BMO = before market open, AMC= after market close). The company will report its next earnings on Oct 27 - Oct 31 (Est.
Alkermes PLC (ALKS) Lowered to "Hold" at Zacks Investment Research  Community Financial News
Alkermes PLC (ALKS) CMO Elliot Ehrich Sells 5000 Shares of Stock
Alkermes PLC logo Alkermes PLC (NASDAQ:ALKS) CMO Elliot Ehrich sold 5,000 shares of the business's stock in a transaction on Friday, September 16th.
Top Earnings to Watch for: Alkermes plc (NASDAQ:ALKS)  The Voice Registrar
Snapshot of Avg. Earnings Forecasts: Alkermes plc (NASDAQ:ALKS)  WsNews 4investors
Alkermes plc (NASDAQ:ALKS) Earnings Preview: Should Investors Be Nervous?
Alkermes plc (NASDAQ:ALKS) got boosted by 1.71 per cent through the trading floor to reach at $46.49 as its next quarterly earnings report date is October 27, 2016.
Alkermes plc (NASDAQ:ALKS) missed earnings on 6 occasions  The Independent Republic